Posts with tag Biosimilars

Sort by Latest
The Return of Biosimilar Substitution in France
Every year the Social Security Financing Law for 2022 (LFSS 2022) introduces several measures resulting in important changes for the life sciences sector and the health insurance system. One of the recent changes of note include the reintroduction of biosimilar substitution, which will allow pharmacists to substitute a biosimilar for the prescribed (reference) biological under certain conditions. Similar legislation enabling biosimilar substitution has existed previously in France. Introduced by...
March 28, 2022
3 min read
Badmouthing Your Competitor’s Products: When Does Denigration...
Over the past decade, different competition authorities across...
February 20, 2020
25 min read
Dutch competition authority ACM publishes a sector...
The Dutch competition authority, ACM, initiated a market study...
October 7, 2019
5 min read